Patents by Inventor Lisa Grace Sabbadini

Lisa Grace Sabbadini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • One dose vaccination with Mycoplasma hyopneumoniae
    Patent number: 6846477
    Abstract: The present invention relates to methods for treating or preventing a disease or disorder in an animal caused by infection by Mycoplasma hyopneumoniae (M. hyo) by administering to the animal at approximately three (3) to ten (10) days of age, a single dose of an effective amount of a M. hyo vaccine. The M. hyo vaccine can be a whole or partial cell inactivated or modified live preparation, a subunit vaccine, or a nucleic acid or DNA vaccine. The M. hyo vaccine administered in accordance with the present invention can be synthesized or recombinantly produced.
    Type: Grant
    Filed: June 19, 2002
    Date of Patent: January 25, 2005
    Assignees: Pfizer Inc., Pfizer Products Inc.
    Inventors: Robin Lee Keich, Lisa Grace Sabbadini
  • One dose vaccination with mycoplasma hyopneumoniae
    Publication number: 20030109473
    Abstract: The present invention relates to methods for treating or preventing a disease or disorder in an animal caused by infection by Mycoplasma hyopneumoniae (M. hyo) by administering to the animal at approximately three (3) to ten (10) days of age, a single dose of an effective amount of a M. hyo vaccine. The M. hyo vaccine can be a whole or partial cell inactivated or modified live preparation, a subunit vaccine, or a nucleic acid or DNA vaccine. The M. hyo vaccine administered in accordance with the present invention can be synthesized or recombinantly produced.
    Type: Application
    Filed: June 19, 2002
    Publication date: June 12, 2003
    Applicant: Pfizer Inc.
    Inventors: Robin Lee Keich, Lisa Grace Sabbadini
  • One dose vaccination with
    Patent number: RE44399
    Abstract: The present invention relates to methods for treating or preventing a disease or disorder in an animal caused by infection by Mycoplasma hyopneumoniae (M. hyo) by administering to the animal at approximately three (3) to ten (10) days of age, a single dose of an effective amount of a M. hyo vaccine. The M. hyo vaccine can be a whole or partial cell inactivated or modified live preparation, a subunit vaccine, or a nucleic acid or DNA vaccine. The M. hyo vaccine administered in accordance with the present invention can be synthesized or recombinantly produced.
    Type: Grant
    Filed: March 2, 2012
    Date of Patent: July 30, 2013
    Assignee: Zoetis LLC
    Inventors: Robin Lee Keich, Lisa Grace Sabbadini